TuttoCongressi
E-mail
Password
Resta Collegato

Cerca per parole nell'archivio:


In archivio:
  • N° Relazioni: 53187
  • N° Accessi Relaz.: 123509
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

   Mostra tutti | Mostra contenuti EasyRec   
28/02/2008
Affari1
11.00 - 13.00
PLENARY SESSION - FROM OVULATION TO PREGNANCY
Tarlatzis Basil 
The use of GnRH antagonists in ovarian stimulation for IVF
Barri Pedro N. 
Pros and Cons of mild ovarian stimulation in ART
Devoto Luigi 
Resistance to Clomiphene Citrate in PCO patients, how to proceed?
Schenker Joseph 
Ovariah Hyperstimulation Syndrom OHSS - pathophysiology, prevention
14.00 - 16.00
PLENARY SESSION - BENIGN UTERINE DISEASES
Cela Vito 
Robotic approach to myomectomy
Angioni Stefano 
Surgical management of deep infiltrating endometriosis
16.20 - 16.50
SPONSORED LECTURE - SOLVAY
Lunenfeld Bruno 
TRT & metabolic syndrome
17.00 - 19.00
SPONSORED SYMPOSIUM- IBSA - LAST GENERATION OF HUMAN FSH: ROAD MAP FOR QUALITY FEATURES AND CLINICAL OUTCOMES
Filicori Marco 
Pharmacological and clinical implications of FSH isoforms
Selman Helmy Ahmed 
Effect of two differently glycosilated FSHs on oocyte quality and clinical outcomes
Al-Inany Hesham 
Performance of commercially available HP-FSHs: a meta-analysis
 
Affari2
11.00 - 13.00
PLENARY SESSION - BREAST DEVELOPMENT, FUNTION AND BENIGN BREAST DISEASES
Bruni Vincenzina 
Pubertal development and the breast
Russo Irma H. 
Hypothalamic control of breast development - implications on breast cancer risk
Russo José 
Differentiation and development of the breast: its significance in cancer and prevention
Foidart Jean-Michel 
Hormones in women with benign breast diseases, and the risk of breast cancer
14.00 - 19.00
1° CONGRESSO NAZIONALE ISGE ITALIA - CORSO A - SPONSORED BY GRUNENTHAL-FORMENTI CONTRACCEZIONE ORMONALE: DA UN'ESIGENZA RIPRODUTTIVA ALLA TUTELA DELLA SALUTE
Genazzani Andrea R. 
Le nuove formulazioni estroprogestiniche
Scarselli Gianfranco 
Quando la contraccezione estroprogestinica confina con la terapia
Bruni Vincenzina 
Quale valutazione clinica e di laboratorio prima del trattamento con associazioni estroprogestiniche (Linee Guida WHO 2004)
Bucciantini M. Sandra 
La contraccezione EP e le interferenze farmacologiche
Dei Metella 
Le giovanissime e la contraccezione
 
Auditorium
10.00 - 11.00
OPENING CEREMONY
Opening ceremony 
Opening ceremony
Studd John 
History of HRT
11.00 - 13.00
SPONSORED SYMPOSIUM-THERAMEX - THE BENEFITS OF THE TRANSDERMAL ADMINISTRATION IN HRT
Skouby Sven 
What should drive the choice between transdermal or oral hormonal administration in HRT?
Postruznik Drazen 
Details from the clinical experience with transdermal HRT
14.00 - 16.00
PLENARY SESSION - MENOPAUSE, HORMONE REPLACEMENT THERAPY AND THE BRAIN
Brinton Roberta Diaz 
Optimizing estrogens and progestins for maximizing benefit in the brain
Birkhaeuser Martin 
Menopause, the brain and symptoms development
Maki Pauline 
Relationship between menopausal symptoms and memory dysfunction in midlife women
Genazzani Andrea R. 
Progesterone effects on brain neurosteroids and opioids
16.20 - 16.50
PLENARY LECTURE
Strigini Francesca 
Update on Prevention and Management of Postpartum Haemorrhage
 
Onice
11.00 - 13.00
ORAL COMMUNICATIONS - OVARIAN FUNCTION AND DYSFUNCTION
Zerbetto Irene 
Role of FSH receptor and DAZL gene polymorphisms in menopausal women
Yang Hoe-Saeng 
Ovarian Function Preservation from Using Cyclophosphamide and Paclitaxel by Concomitant Administration of GnRHa I, GnRHa II or GnRH antagonist in ICR Mice
Bhangoo Amrit 
Genotype-Phenotype Link in 46, XX Females with Steroidogenic Acute Regulatory Protein (StAR) Mutations
Purushothaman Radhika 
Anti-Mullerian Hormone as a Marker of Ovarian Reserve in Young Girls with Turner's Syndrome
Sinha Prabha 
Very premature ovarian failure - A case report
Rizzello Francesca 
Post-surgical premature ovarian failure and ovarian cysts recurrence. Ovulation post-laparoscopic management
14.00 - 16.00
SPECIAL SESSION - PROGESTIN CLUB - PROGESTOGEN AND THE ENDOMETRIUM
E. Thijssen Josef 
Gene polymorphism and Progestogen
Huber Johannes 
Progesterone- and Estrogen- Receptor Isoforms and Endometrium
Zahradnik Hans Peter 
Progestogen and Endometrial Regulation: Theoretical and Clinical considerations
Druckmann René 
Long-term use of progestogens-getting the balance right:Molecular biology and the endometrium
16.20 - 19.00
ORAL COMMUNICATIONS - HIGH-RISK PREGNANCY
Limone Andrea 
Home fetal heart rate monitoring: efficacy evaluation program and pregnants acceptability
Mandò Chiara 
Insulin-like growth factor ii (igf2) and h19 expression in iugr
Chedraui Peter 
Plasma and placental nitric oxide levels in Ecuadorian gestations complicated with preeclampsia living at different altitude
 
Quattro
11.00 - 13.00
ORAL COMMUNICATIONS - HYPERANDROGENISMS AND PCOS
Ilovayskaya Irena 
Androgen status in women with hypogonadotropic amenorrhea
Xu Wen 
ERK1/2 activation by testosterone inhibits insulin induced glucose uptake in C2C12 myotubes
Goglia Lorenzo 
The effects of testosterone and dihydrotestosterone on endothelial nitric oxide synthase activity and on the expression of pai-1 and t-pa in human andothelial cells
Kinoshita Toshihiko 
Measurement of serum bioavailable testosterone using liquid chromatography/tandem mass spectrometry in polycystic ovarian syndrome
Lindén Hirschberg Angelica 
Menstrual status and hyperandrogenism in olympic athletes in power, endurance and technical disciplines
Gambera Alessandro 
Adiponectin modulation by hyperandrogenism and insulin-resistance in polycystic ovary syndrome and normal women
Kajaia Natia 
Influence of subclinical hypothyreosis on insulin resistance in women with hyperandrogenism
Tang Ting-Ting 
Investigation of menstrual cyclicity and determination of upper limits for serum androgen and insulin resistance in adolescent girls
Hagmar Magnus 
Body composition and biomarkers of energy availability in female olympic athletes
14.00 - 16.00
ORAL COMMUNICATIONS - STEROID RECEPTORS SIGNALING
Moretti Costanzo 
Genes involved in androgen excess in women: possible role of the insulin in endothelial pathway
Sager Georg 
Progesterone and mifepristone in high doses act in synergy to inhibit growth of endometrial cancer (Ishikawa) cells
Schmidmayr Monika 
The influence of concentration and cyclicity of progesterone on proliferation and differentiation of human osteoblasts in vitro - Progesterone enhances differentiation of human osteoblasts in long-term-culture
Saragueta Patricia 
Crosstalk of steroid receptors and pERK in endometrial stromal cells
16.20 - 19.00
ORAL COMMUNICATIONS - GYNECOLOGICAL ONCOLOGY
Wildemeersch Dirk 
Long-term follow-up of patients with non-atypical and atypical endometrial hyperplasia treated with a levonorgestrel-releasing intrauterine system?An alternative to hysterectomy
Lindén Hirschberg Angelica 
Effects of testosterone addition to estrogen on endometrial proliferation and expression of sex hormone receptors in postmenopausal women
Moszynski Rafal 
Correlation between endothelin-1 concentration and ultrasonography Doppler findings in patients with ovarian tumors
Szpurek Dariusz 
Non-epithelial ovarian tumors evaluated by ultrasonographic morphological index
 
Verde
11.00 - 13.00
SPONSORED SYMPOSIUM - REPROS - EFFECTS OF PROGESTERONE RECEPTOR MODULATORS IN FEMALE REPRODUCTIVE HEALTH WITH EMPHASIS ON THE ENDOMETRIUM
I. M. Spitz 
Introduction
I. M. Spitz 
Conclusions
14.00 - 16.00
PLENARY SESSION - PRETERM LABOR, INTRAUTERINE GROWTH RESTRICTION AND HYPERTENSIVE DISORDES OF PREGNANCY
Sibley Colin P. 
Intrauterine fetal growth and placental function
Baker Philip 
Preeclampsia and endothelial function
E. Ferrazzi 
Utero-placental oxygen exchange and inflammation in preeclampsia and intrauterine growth restriction
16.20 - 16.50
SPONSORED LECTURE - MELBROSIN
Chedraui Peter 
The clinical efficacy of red clover isoflavones in the treatment of menopausal symptoms
17.00 - 19.00
SPONSORED SYMPOSIUM- SE-CURE - FEMARELLE, A NEW HORIZON IN MENOPAUSE MANAGEMENT
Naftolin Frederick 
The Effect of Long Term Estrogen Deficiency at the Menopausal Period
Genazzani Andrea R. 
Welcome
Yoles Israel 
The Research on Femarelle: Past, Present and Future
Nachtigall Lila E 
Femarelle, the First Line Treatment for the Management of Menopause
 
29/02/2008
Affari1
08.30 - 10.00
PLENARY SESSION - IVF
Artini Paolo G. 
Vitrification: a promising cryopreservation method in ART
Shoham Zeev 
Can we increase implantation rate? A clinical approach
Ben-Rafael Zion 
Agonist or antagonist what is preferable for in vitro fertilization (IVF)?
10.10 - 10.40
PLENARY LECTURE
Simon Carlos 
The creation of gametes from stem cells
11.00 - 13.00
PLENARY SESSION - THE POLYCYSTIC OVARY SYNDROME
Franks Steve 
Development of polycystic ovary syndrome: involvement of genetic and environmental factors
Skouby Sven 
Metabolic and cardiovascular consequences of PCOS
Kotsuji Fumikazu 
Weight-loss induces oligomenorrhea with increased LH/FSH ratio and polycystic ovary
Ibanez Lourdes 
Polycystic Ovary Syndrome:the new treatment options
Fulghesu Anna Maria 
Ultrasound in PCOS: Revisiting Rotterdam criteria
15.10 - 17.10
PLENARY SESSION - THE BONE
Palacios Santiago 
Hypogonadism and peak bone mass
Gambacciani Marco 
HRT and bone health
17.30 - 19.30
PLENARY SESSION - THE METABOLIC SYNDROME IN WOMEN
Ozanne Susan 
Pre-natal origins of adult metabolic syndrome
Chedraui Peter 
The metabolic syndrome in the menopause
Lanzone A., Romualdi D. 
Insulin resistance and women's health
Milewicz Andrzej 
Obesity and women's health
 
Affari2
08.30 - 10.00
PLENARY SESSION - A NEW PLAYER AND TARGET IN GYNECOLOGICAL ENDOCRINOLOGY: AROMATASE
Labrie Fernand 
Intracrinology of the breast
Maia Hugo 
Aromatase and the endometrium
Garcia ? Segura Luis Miguel 
Aromatase and the brain
11.00 - 13.00
PLENARY SESSION - HUMAN AGEING: THE ENDOCRINE IMPACT
Huber Johannes 
Genetic polymorphism in female ageing
Whalley Lawrence 
The neurobiology of brain ageing: implications for cognitive health and neuroendocrine dysregulation
Lobo Rogerio 
Metabolic consequences of ageing in women
Neves-e-Castro Manuel 
A holistic approach for the improvement of health and disease prevention for the middle-aged woman
14.30 - 19.30
1° CONGRESSO NAZIONALE ISGE ITALIA - SPONSORED BY WYETH - CORSO B: LA TERAPIA ORMONALE IN MENOPAUSA: A CHI, PERCHE', COME E PER QUANTO TEMPO
Melis Gian Benedetto 
Inquadramento clinico-diagnostico della donna in menopausa
Biglia Nicoletta 
Impatto della cultura personale sull'utilizzo della TOS: una lezione dalla ricerca scientifica
Nappi Rossella 
La TOS come terapia: La donna in menopausa precoce
Becorpi Angelamaria 
La TOS come terapia - TOS: a chi come e quanto. La perimenopausa
Martignoni Emilia 
La donna a rischio di patologie neurodegenerative
Gambacciani Marco 
La TOS come terapia - La donna con rischio osteoarticolare
Sismondi Piero 
La TOS come terapia - La donna a rischio oncologico
Mencacci Claudio 
Disturbi affettivi nelle donne
Genazzani Andrea R. 
TOS: per quanto tempo
 
Auditorium
08.30 - 10.00
PLENARY SESSION - THE OVARY FROM OVULATION TO MENOPAUSE
Ishizuka Bunpei 
Premature ovarian failure: an update
Lachowsky Michèle 
Premature menopause: how to support our patients
Meczekalski Blazej 
Oocyte specific genes and their role in ovarian function and dysfunction
Del Pup Lino 
Improving quality of life of menopausal cancer patients
11.00 - 12.00
ISGE SPECIAL SESSION - SYMPOSIUM I
Graziottin Alessandra 
Prevalence of HSDD in Europe and relevance of disorder
Panay Nicholas 
Diagnosis and management of low sexual desire
14.30 - 15.00
PLENARY LECTURE
Korach Ken 
Estrogen receptor action in ovarian physiology
15.10 - 17.10
SPONSORED SYMPOSIUM SOLVAY - EMBRACING FEMALE LIFE - DUPHASTON, THE IDEAL PROGESTOGEN
Arck Petra 
The 1000 Pregnant Women Study
Daya Salim 
The Ideal Progestogen to Protect Pregnancy
Panay Nicholas 
How to Effectively Treat Menstrual Disorders
Foidart Jean-Michel 
Recent Study Results on HRT Combinations
17.30 - 19.30
SPONSORED SYMPOSIUM IBSA - PROGESTERONE IN PREGNANCY
Jasonni Valerio Maria 
Progesterone: from its beginnings to today
Diedrich Klaus 
Role of progesterone in the stimulated cycle and in pregnancy
De Ziegler Dominique 
Efficacy of subcutaneous progesterone for priming endometrial receptivity
Facchinetti Fabio 
Clinical and laboratory findings of 17?-hydroxy-progesterone in women at risk for preterm delivery
 
Onice
08.30 - 10.40
ORAL COMMUNICATIONS - GYNECOLOGICAL SURGERY
Siesto Gabriele 
Laparoscopic colorectal resection for severe endometriosis with transvaginal specimen extraction
Rizzello Francesca 
Does ovarian surgery influence age at menopause? Results from long-term follow up of women with endometriosis
Ahonkallio Sari 
Diagnostics of endometrial function after thermal ablation
Di Lieto Andrea 
Leiomyoma pseudocapsule after pre-surgical medical treatment: immunohistochemical changes and clinical effects
Artymuk Natalia 
A new approach to the management of endometrial hyperplasia in women with obesity
Coppola Marina 
Peritoneal leptin levels in women with ovarian endometriosis: association with different laparoscopic findings
Stolnicu Simona 
Mullerian adenosarcoma of the uterus associated with tamoxifen treatament
11.00 - 13.00
SPECIAL SESSION SOBRAGE - CONTRIBUTION TO GYNECOLOGICAL ENDOCRINOLOGY
Maia Hugo 
HRT with subdermal implants of estradiol and testosterone
Bonassi Rogerio 
Clinical and epidemiological aspects of cephaleas, particularly migraine, in oral contraceptive users
Maia Hugo 
Menstruation, inflammation and aromatase expression in the endometrium
Spinola Paulo 
dvantages and disadvantages of contraception with subdermal implants
14.30 - 15.00
SPONSORED LECTURE - GRUNENTHAL
Huber Johannes 
Effects of an oral contraceptive with chlormadinone acetate and ethinylestradiol on depressive mood: the cma-gabaa model
15.10 - 17.10
SPECIAL SESSION SOC. FRANCOPHONE DE CONTRACEPTION - INNOVATIONS ET PERSPECTIVES EN CONTRACEPTION
Foidart Jean-Michel 
Intérêt de la drospirénone en contraception et en traitement hormonal de la ménopause
Sitruk Ware Regine 
Contraception transdermique sand patch
Bitzer Johannes 
Contraception et sexualité : toutes les pilules sont-elles équivalentes ?
17.30 - 19.30
SPECIAL SESSION POLISH GYNECOLOGICAL SOCIETY - CURRENT ENDOCRINE PROBLEMS IN OBSTETRICS AND GYNAECOLOGY
Jakimiuk Artur 
Contraception in the adolescent patient
Spaczynski Robert 
Treatment modalities in symptomatic endometriosis
Kurzawa Rafal 
Possible links between genetic and environmental factors in male infertility
Pawelczyk Leszek 
Can statins be a new therapeutic option in the treatment of polycystic ovary syndrome (PCOS) ?
 
Quattro
08.30 - 10.40
ORAL COMMUNICATIONS - POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY
Belo Najara 
Impairement of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for menopause associated obesity and hypertension
Ringa Virginie 
Influence of the publication of the WHI on HT use among French postmenopausal women followed since 1990
Wildemeersch Dirk 
Long-term endometrial safety of continuous combined transdermal estrogen and intrauterine levonorgestrel
Postruznik Drazen 
Cardiovascular diseases and hrt in france : mission study prospective phase results
Vujovic Svetlana 
A ten years follow up study of cardiovascular risk factors in menopausal women
Rajtar-Ciosek Agnieszka 
Inflammatory markers and antibodies against heat shock proteins 60 (HSP60) in menopausal women
Erdem Ahmet 
A randomized study comparing the effects of two oral estrogen replacement regimens and black cohosh on cardiovascular risk markers in postmenopausal women
Ozansoy Gulgun 
The effects of combination of hormone replacement therapy with atorvastatin on vascular functions of ovariectomized rats
Zervoudis Stefanos 
Sequential tibolone or progestin for premenopausal bleeding
Tian Qinjie 
Long-term Low Dose Intermittent Hormone Therapy (LLI-HT) Reduced the Atrophy Degree of Brain Hippocampus in Postmenopausal Women
Rossmanith Winfried G. 
Thermoregulation in the human: a base for new therapeutical approaches
Tancic-Gajic Milina 
Effects of ten years hormone replacement therapy on insulin resistance in the menopause
Barac Branko 
Effects of different hormone replacement therapy (HRT) regimens on bone mineral density in menopausal women
11.00 - 13.00
ORAL COMMUNICATIONS - THE BREAST
Bloise Enrrico 
Increased follistatin expression in human breast tumors
Pfeiler Georg 
Loss of LH/hCG receptor expression in invasive breast cancer tissue compared to preinvasive component
Kalkhake Kathrin 
Effect of testosterone and tibolone on purified 17beta-HSD 1 from human placenta and mammary gland
Attari Farnoosh 
study of apoptosis in lactotrop cells invitro
Damian-Matsumura Pablo 
Estradiol induce divergent angiogenin expression in human breast cancer
Siesto Gabriele 
Percutaneous sonographically guided radiofrequency ablation for the management of symptomatic uterine myomas
14.30 - 17.10
ORAL COMMUNICATIONS - FRONTIERS IN OBSTETRICS
Borges Lavinia Estrela 
Expression of urocortin by human umbilical vein endothelial cells: cytokines, endothelin and dexamethasone stimulates urocortin secretion
Spedicato Massimo 
Effects of rosiglitazone, a ppar-gamma agonist, on the contractility of bovine myometrium in vitro
G. Distante 
Thyroid function and obstetrical complications: a prospective study
Pelle Francesca 
Maternal, fetal and neonatal outcomes in pregnancies complicated by graves'disease: importance of a close teamwork between obstetricians and endocrinologists
Stefanidou Eratu Maria 
Thyroid autoimmune disease and reproduction
Cezar Cristina 
Management of hypertyroidism in pregnancy
Sommella Ciro 
Serum TSH levels and pregnancy outcome: a retrospective study
Chedraui Peter 
Maternal serum proinflammatory cytokines levels and their relation to the latency period duration in gestations complicated with preterm premature rupture of membranes
Sennstrom Maria 
Cervical ripening at term involves activation of apoptotic enzymes
Galleri Letizia 
Increased expression of KiSS-1 in preterm placenta
Amash Alaa 
Magnesium Sulfate Differently Affects Interleukin-1 Receptor Antagonist Release by Perfused Term Normotensive and Preeclamptic Human Placenta
Luksha Leonid 
Endothelial function and contribution of EDHF in small arteries from women with preeclampsia
Pisaneschi Sivlia 
Combined functional and molecular analysis of endothelial cells from umbilical vessels of fetuses with normal or restricted intrauterine growth
Hill Martin 
Steroid metabolomic profile during human late pregnancy
17.30 - 19.30
ORAL COMMUNICATIONS - NEW IMAGING TECHNIQUES
Dragojevic-Dikic Svetlana 
Doppler Sonography analysis of uterine arteries in spontaneous and artifially induced manopause
Ignacchiti Erika 
Measurement of maternal serum inhibin A levels and trophoblast volume by three dimensional ultrasound may predict pregnancy outcome in women with threatened abortion
Luchi Carlo 
MATERNAL AND FETAL DOPPLER FINDINGS IN WOMEN WITH CHRONIC HYPERTENSION: THE ROLE OF ARCHIMETRA AND FETAL RENAL ARTERIES DURING THE FIRST TRIMESTER OF PREGNANCY
Lanzani Chiara 
The role of 2D-HyCoSy with contrast tuned imaging technology for the assessment of tubal patency in an infertility program
Kajaia Natia for Lutidze Rita 
Application of the magnetic fluid Unimag during dynamic echohysterosalpingoscopy in the experimental study
Papadia Luigi Salvatore 
Recurrent abortion in hysteroscopy
Szczublewski P 
Comparison of Sonomorphological Index and Doppler Index In Preoperative Diagnosis Of Functional Ovarian Tumors
Jugeli Madona 
Opportunities of Colposcopy in the Diagnostics of Chlamydia-Mycoplasmatic Cervicitis
 
Verde
08.30 - 10.40
ORAL COMMUNICATIONS - SEXUALITY
Mancini Fulvia 
Clitoral vascularization and menstrual cycle
Taavoni Simin 
Postpartum sexual function and related sex factors changes during 3-6 months after delivery, eastern Theran
Uccella Stefano 
Is urinary incontinence at orgasm really related to detrusor overactivity? A prospective study to assess pathogenesis and treatment
Nappi Rossella 
LEI (Lack of Testosterone Impact) survey in a sample of italian women with surgical menopuase
11.00 - 13.00
PLENARY SESSION - ENDOMETRIAL CANCER
Laios Alexandros 
Genome-wide analysis of DNA in endometrial cancer using comparative genomic hybridization microarrays
Orbo Anne 
Bcl-2, BAX and apoptosis in endometrial hyperplasia after high dose gestagen therapy. A comparison of responses in patinets treated with intrauterine Levonorgestrel and systemic medroxyprogesterone
Gadducci Angiolo 
Molecular target therapies in endometrial cancer
14.30 - 15.00
PLENARY LECTURE
Perez Lopez Faustino 
The vitamin D endocrine system and women's health
15.10 - 17.10
PLENARY SESSION - NEW DEVELOPMENT IN THE IMAGING OF PELVIC ORGANS
Testa Antonia Carla 
The role of ultrasound in the diagnosis and follow up of ovarian cancer
Kurjak Asim 
The fuctional and structural assessment of early human development - what does 3D/4D sonography add
Creatsas George 
New diagnostic and management techniques of uterovaginal anomalies with obstruction
Lewin Aby 
Current role of ultrasound in Assisted Reproduction
17.30 - 19.30
SPECIAL SESSION SOCIETE EUROPEENNE DE GYNECOLOGIE - MAMMARY PATHOLOGIES AMONG ADOLESCENT GIRLS
Foidart Jean-Michel 
Hypoplasia and Hyperplasia Pathogenic mechanisms and treatment
Desreux Joelle 
Malignant breast tumors at puberty
Simoncini Tommaso 
The endocrine sensitivity of breast cells to natural and synthetic steroids at adolescence
Bitzer Johannes 
Contraception in the young adolescent: impact on the breast
 
01/03/2008
Affari1
08.30 - 10.00
PLENARY SESSION - SEX STEROIDS AND THE ENDOMETRIUM
Kuhl Herbert 
Sex Steroid signalling in the endometrium
Al-Azzawi Farook
SERMs and the endometrium
10.10 - 10.40
SPONSORED LECTURE - MELBROSIN
Simoncini Tommaso 
Red clover isoflavones and the postmenopausal woman: the molecular basis for safety and efficacy
11.00 - 13.00
PLENARY SESSION - THE HYPOTALAMUS-PITUITARY-OVARY AXIS AND THE HYPOTHALAMIC AMENORRHEA
Chrousos George P. 
The role of stress in the pathogenesis of reproductive dysfunction in females
Berga Sarah 
The neuroendocrinology of recovery from functional hypothalamic amenorrhea
Bouchard Philippe 
Hypothalamic amenorrhea: new genetic developments
Genazzani Alessandro D. 
Neuropharmacological approaches to hypothalamic amenorrhea
14.30 - 15.00
PLENARY LECTURE
Fauser Bart 
How to define successful In Vitro Fertilization
15.10 - 17.10
PLENARY SESSION - STEROID RECEPTORS
Beato Miguel 
Transcriptional and non-transcriptional signalling of steroid hormones
Brandi Maria Luisa 
Genetics and pharmacogenetics of estrogen response
Funder John 
Mineralocorticoid receptors and women's health
Schumacher Michael 
Progesterone signalling in the nervous system
McDonnell D. 
Mining the complexities of the estrogen and progesterone signalling pathways for new therapeutic targets
17.30 - 19.30
PLENARY SESSION - NEW CONCEPTS IN CLIMACTERIC MEDICINE
Simoncini Tommaso 
Breast and cardiovascular actions of Estetrol (E4)
Cagnacci Angelo 
Postmenopausal osteoporosis: relation with Folates, vitamin B12 and Homocysteine
Dinger Juergen 
The safety of HRT under real life conditions: interim results from the EURAS-HRT study
 
Affari2
08.30 - 13.30
1° CONGRESSO NAZIONALE ISGE ITALIA - SPONSORED BY PROCTER&GAMBLE - TESTOSTERONE E SALUTE SESSUALE FEMMINILE
Graziottin Alessandra 
Le disfunzioni sessuali femminili: focus sul disturbo del desiderio sessuale ipoattivo
Nappi Rossella 
Il ruolo emergente del Testosterone nella terapia delle disfunzioni sessuali femminili
Becorpi Angelamaria 
Casi Clinici
14.30 - 19.30
1° CONGRESSO NAZIONALE ISGE ITALIA - SPONSORED BY GUIDOTTI - DALLA INSULINO RESISTENZA AL DIABETE MELLITO TIPO 2
Bruni Vincenzina 
Sviluppo puberale e peso corporeo
Lanzone Antonio 
Iperandrogenismo, resistenza insulinica e massa corporea
Genazzani Alessandro D. 
La PCOS: diagnostica endocrina e strategia terapeutica
Fulghesu Anna Maria 
Diagnostica ecografica della PCOS
Moghetti Paolo 
Il rischio di diabete tipo 2 nella paziente con insulino-resistenza
Palomba Stefano 
Induzione dell'ovulazione in pazienti con insulino-resistenza: ruolo dei farmaci insulino-sensibilizzanti
Valensise Herbert Carmelo C. 
Management della gravida diabetica
Di Carlo Costantino 
Menopausa, resistenza insulinica ed obesità
 
Auditorium
08.30 - 10.00
PLENARY SESSION - IMPLANTATION, EARLY EMBRYO DEVELOPMENT
Taylor Hugh 
Genetic regulation of implantation
Carp Howard 
The fetal factor in recurrent pregnancy loss
Agrawal Veena 
Antiphospholipid Syndrome (Hughes Syndrome: APS) and recurrent pregnancy loss
10.10 - 10.40
SPONSORED LECTURE - ROTTAPHARM
Bohbot Jean Marc 
Vaginal ecosystem balance and quality of life
11.00 - 13.00
SPONSORED SYMPOSIUM - NOVONORDISK - THE IMPORTANCE OF THE PROGESTOGEN DOSE
Sturdee David and Bo von Schoultz 
Welcome
Birkhaeuser Martin 
Current trends in HRT - perceptions and usage
Barlow David H. 
Why is the progestogen important?
Kuhl Herbert 
Are all progestogens the same?
Panay Nicholas 
Ultra low dose HRT - the evidence
Gambacciani Marco 
Ultra low dose HRT - benefits for the bones
Sturdee David and Bo von Schoultz 
Panel discussion and concluding remarks
14.30 - 15.00
PLENARY LECTURE
Mendelsohn Michael 
Estrogen receptor actions in the cardiovascular system
15.10 - 17.10
SPONSORED SYMPOSIUM - BAYER SCHERING - CURRENT MENOPAUSE MANAGEMENT: THE IMPORTANCE OF SELECTINE THE PROGESTIN
Genazzani Andrea R., Mendelsohn Michael 
Introduction
Gambacciani Marco 
Managing the menopause, with special focus on Angeliq
Simoncini Tommaso 
Effects of Drospirenone on breast tissue and the cardiovascular system
Mikkola Tomi 
Menopausal HT: cardiovascular aspects
Genazzani Andrea R., Mendelsohn Michael 
Conclusions
17.30 - 19.30
SPONSORED SYMPOSIUM - ORGANON - THE MODERN ERA OF CONTRACEPTION: TAILORING TO PATIENT PREFERENCES
Ho Pak Chung 
Introduction
Zieman Miriam 
Exploring contraceptive options for women: What do women really want?
Blumenthal Paul 
Regional differences in contraceptive practices: All women are not the same
Hillard Paula 
Beyond combined oral contraception: A focus on nontraditional contraceptive methods
Bitzer Johannes 
The modern era of contraception: a focus on patient satisfaction
Panel Discussion 
Panel Discussion
 
Onice
08.30 - 10.40
SPECIAL SESSION SIGITE - ACTUALITY IN MENOPAUSE AND AGING
Stomati Massimo 
Androgens: new options for the treatment of postmenopausal women
Becorpi Angelamaria 
Menopause: the role of information
11.00 - 13.00
SPECIAL SESSION SIERR - DEVELOPMENT OF MOLECULAR MARKERS RELATED TO GAMETE QUALITY
Gandolfi Fulvio 
Non-invasive evaluation of oocyte developmental competence
Stuppia Liborio 
Gene expression profiles in fresh and cryopreserved human oocytes
Tarozzi Nicoletta 
Sperm quality in assisted reproduction: clinical relevance of DNA damage
13.00 - 16.10
SPECIAL SESSION ISPOG - HOW CAN PSYCHOSOMATICS BE USEFUL IN OBSTETRICS AND GYNECOLOGY? EXAMPLES FROM VARIOUS FIELDS
Bitzer Johannes 
Psychosomatic care in patients with endometriosis
Wimmer-Puchinger Beate 
Body modification offends women: eating disorders, beauty surgery and "designer vagina" Issues influencing womens selfesteem and theri body image: a psychosomatic approach
Kentenich Heribert 
Female genital mutilation as violence against every woman
Lal Mira 
Obstetric and gynaecological implications of gender violence
Abraham Suzanne 
Eating disorders and women's health
17.30 - 19.30
SPECIAL SESSION GERMAN ENDOMETRIOSIS RESEARCH - FOUNDATION AND THE EUROPEAN ENDOMETRIOSE LEAGUE - NEW DEVELOPMENTS IN ENDOMETRIOSIS
Florio Pasquale 
Possible new serum markers for endometriosis
Buchweitz O 
Evaluation of autoflorescence as new diagnostic tool for the diagnosis of endometriosis
Kiesel Ludwig 
Stem-cells in Endometriosis
Tinneberg Hans-Rudolf 
Endometriosis - impact on reproduction
Ulrich Uwe 
Operative options for peritoneal endometriosis
Luisi Stefano 
Analgesics and omega3-fatty acids in the treatment of endometriosis related pain
 
Quattro
08.30 - 10.40
ORAL COMMUNICATIONS - GYNECOLOGICAL DISEASES
Ewies Ayman 
Mirena: Why 50% of women dislike it?
Hakimi Mohamad 
The relationship between macrophage numbers and grade of endometriosis tissue
Baka Stavroula 
The expression of HLA class I and II in the endometrial tissue of women with endometriosis or adenomyosis
de Albuquerque Salles Navarro Paula Andrea 
Endometriosis effect over meiotic spindle and chromosomal configurations of in vitro matured oocytes obtained from stimulated cycles: pilot study
Smuc Tina 
Ovarian endometriosis: TaqMan LDA gene expression study
Umesaki Naohiko 
Long-term personalized GNGH agonist therapy without estrogen supplementation for recurrent extraperitoneal endometriosis
Exacoustos Caterina 
Effects of medical therapy on deep endometriosis: a sonographic study
11.00 - 13.00
ORAL COMMUNICATIONS - RECURRENT ABORTION
Vaquero Elena 
Recurrent spontaneous abortion: three dimensional power Doppler evaluation of endometrial and subendometrial volume and vascularity and correlation to uterine arteries blood flow
Stefanidou Erato Maria 
Etiological factors of recurrent spontaneous miscarriage
Pasquier Elisabeth 
Skewed X-chromosome inactivation and recurrent pregnancy loss. An incident paired case-control study
Vicino Mario 
Insulin-resistance and hyperinsulinemia in women with recurrent abortion
Nicotra Maria 
Reproductive success in women with recurrent spontaneous abortion. The role of Adenosine Deaminase genetic polymorphism
Homer Lionel 
45,X/46,XX mosaicism : impacts on first trimester pregnancy outcome
14.30 - 17.10
ORAL COMMUNICATIONS - FROM OVULATION TO PREGNANCY
Minoia Rosa 
Embryo-maternal communication: is the mu-opioid receptor, one of the possible cross-talking way?
Djaswadi Dasuki 
The success rate of Assisted hatching between freezing/thawing embryos with fresh embryos of Swiss albino rats
Ratti Martina 
Proteomic analysis of endometrium during implantation' s window of blastocystis
de Albuquerque Salles Navarro Paula Andrea 
Meiotic spindle evaluation of bovine oocytes submitted to in vitro maturation after pretreatment with butyrolactone I , an inhibitor of premature meiotic resumption
Vomvolaki Eleytheria 
Interleukin-18 may be used as a predictor of pregnancy outcome in women undergoing in vitro fertilization (IVF)
Darwish Emad 
Evaluation of Anti-Mullerian Hormone as a predictor of ovarian reserve in women with and without PCOS undergoing ICSI
Suturina Larisa 
Processes of lipid peroxidation and antioxidant defense in women with some endocrine factors of sterility
Gerli Sandro 
Cost-effectiveness of recombinant FSH vs human FSH in intrauterine insemination cycles: a statistical model-derived analysis
17.30 - 19.30
ORAL COMMUNICATIONS - PCOS I
Li Yang 
The Effect of Metformin on Cytokines
Lanzoni Chiara 
MYO-INOSITOL administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with Polycystic Ovary Syndrome
Panidis Dimitrios 
Serum adiponectin levels reflect the severity of the polycystic ovary syndrome, independently of obesity and insulin resistance
Perini Daria 
Adolescent girls with Polycystic Ovary Sindrome show impairment of lipid profile associted with hyperandrogenemia indipendent of obesity and insulin resistance
Fiore Cristina 
Polycystic ovary syndrome: implications of aldosterone and progesterone values in the different phases of the cycle
Svendsen Pernille Fog 
Incretins and polycystic ovary syndrome (PCOS)
Mafaldo Soares Gustavo 
Early markers of cardiovascular disease in women with polycystic ovary syndrome
N. Georgopoulos 
SHBG gene (TAAAA)n polymorphism and serum level in women with PCOS during ovarian stimulation for in vitro fertilization
 
Verde
08.30 - 10.40
PLENARY SESSION - HORMONE SENSITIVE BENIGN UTERINE DISEASES
Laudanski Tadeusz 
Hormonal management of dysfunctional uterine bleeding
Fedele Luigi 
Uterine adenomyosis?
Sturdee David 
Management of endometrial hyperplasia
11.00 - 13.00
PLENARY SESSION - ENDOMETRIOSIS: FROM BIOLOGY TO DISEASE CURE
Petraglia Felice 
Local hormonal treatment of endometriosis
Berkley Karen 
Neural mechanism of the pains of endometriosis
Szamatowicz Marian 
Immunological and genetic background of endometriosis
Naftolin Frederick 
Ezrin expression and action in normal and endometriotic human endometrium
14.30 - 15.00
PLENARY LECTURE
Tempone Antonio 
Premature ovarian failure in cancer treated patients
15.10 - 17.10
PLENARY SESSION - NEW CONCEPTS IN CONTRACEPTION
Sitruk Ware Regine 
New delivery systems and progestins: what changes in contraception?
Spinola Paulo 
Perimenopausal contraception
Ho Pak Chung 
Recent advances of medical abortion
17.30 - 19.30
SPECIAL SESSION INT. ACADEMY OF HUMAN REPRODUCTION - REPRODUCTIVE MEDICINE 2020
Tatone Carla 
Possible involvement of AGEs (Advanced Glycation End-products) in ovarian aging
Kurjak Asim 
Contribution of ultrasound in assisted reproduction
Monteleone Patrizia 
Correlation between angiogenic growth factors and perifollicular blood flow in patients undergoing in vitro fertilization
Schenker Joseph 
Preimplantation diagnosis: medical and ethical aspects
 
02/03/2008
Affari1
08.30 - 10.30
HORMONES AND BREAST CANCER: FROM BASIC RESEARCH TO CLINICAL APPLICATIONS
Chang Chawnshang 
Abnormal mammary gland development and growth retardation as well as subfertility and defective folliculogenesis in female mice lacking androgen receptor
Fu Xiao Dong 
Sex steroid actions on the cytoskeleton and movement in breast cancer cells
11.00 - 11.30
PLENARY LECTURE
Baum Michael 
Fertility and adjuvant therapy for early breast cancer
11.30 - 13.30
HORMONES AND BREAST CANCER CLINICAL ISSUES
Mueck Alfred O. 
Estrogen metabolism and breast cancer
Gompel Anne 
Progesterone isoforms and progestin effects in the breast
Von Schoultz Bo 
Breast density and hormonal therapy
Sismondi Piero 
HRT and breast cancer
 
Affari2
09.30 - 13.30
RALOXIFENE E OSTEOPOROSI POST-MENOPAUSALE: UN TRATTAMENTO CON MOLTI VANTAGGI
Brandi Maria Luisa 
Osteoporosi post-menopausale, fisiopatologia, clinica e impatto sociale
Simoncini Tommaso 
Raloxifene: dalle azioni molecolari alla funzione, dalla funzione alla clinica
Amunni Gianni 
Raloxifene e sicurezza clinica: azione su utero e mammella
 
Auditorium
08.30 - 10.30
MENOPAUSE, HORMONE REPLACEMENT THERAPY AND THE CARDIOVASCULAR SYSTEM
Simoncini Tommaso 
Estrogens and progestins and the cardiovascular system
Kublickiene Karolina 
Small artery function and HRT
Pines Amos 
Benefit-risk assessment of HRT in the early postmenopause
Stevenson John 
HRT and cardiovascular system: the window of opportunity
11.00 - 11.30
PLENARY LECTURE
Maruo Takeshi 
Regulation of extravillous trophoblast invasion in early pregnancy by thyroid hormone
11.30 - 13.30
ANDROGENS AND ANDROGEN RECEPTORS, FROM THE BENCH TO THE BEDSIDE
Sultan Charles 
The androgen receptor
Levine Jon E 
Neuroendocrine consequences of prenatal androgen exposure: implications for the pathogenesis of PCOS
Nappi Rossella 
Hyperandrogenism: impact on adolescent development
Genazzani Andrea R. 
Delta 5-Androgens replacement therapy: new concepts
13.30 - 14.00
CLOSING CEREMONY
Genazzani Andrea R. 
Closing Ceremony
 
Onice
08.30 - 10.30
THE CLIMACTERIC WOMAN AND OSTEOPOROSIS
Lima S. 
Vitamin D receptor gene polymorphisms in families with Osteoporosis
Povoroznyuk V. 
Effect of peptide regulators on structural and functional status of osseous tissue in ageing
Rattenhuber J. 
A prospective 9-year observational study of bone density and fractures in pre-, peri- and postmenopausal women
Goppel K. 
Menstrual cycle characteristics in perimenopausal women with normal and osteopenic bone density: The PEKNO-Study
San Miguel G. 
Quality of life assessment during the menopausal transition
Povoroznyuk V. 
Open Placebo-controlled study the efficacy fo phenibutum (NOOPHEN) in complex treatment chronic neck pain and menopausal symptoms in the women in early postmenopausal period
11.00 - 13.30
HORMONE-SENSITIVE GYNECOLOGICAL DISORDERS
Soares jr JM. 
The metformin effects on the ovaries of androgen-induced permanent estrous.
Seifert-Klauss VR. 
Is there a correlation between ovulation and bone metabolism?
Potì E. 
Female sexuality evaluation in menopausal period
Bixler EO. 
Menopause and hormone replacement therapy: effects on objective sleep patterns
Zanoli P. 
Improved sexual behavior of ovariectomized rats treated with the phytoestrogen ferutinin.
 
Quattro
08.30 - 10.30
WOMAN'S HEALTH FROM ADOLESCENCE TO ADULTHOOD
Vicariotto F. 
SPHG800 is able to reduce irritative and infective vulvitis symptoms
Nanbakhsh F. 
Evaluation of the prognostic value of chlamydia trachomatis antibody testing (CAT) , hsg and laparoscopy in predicting tubal factor infertility(TFI) in motahhari hospital, urmiyeh, iran.
Mueck AO. 
Treatment of migraine with estradiol patches to compensate estrogen withdrawal during cyclic oral contraceptives or hormone therapy
11.00 - 13.30
MEDICALLY-ASSISTED PROCREATION
Jakimiuk A. 
C-reactive protein concentration as the indicator of severity in ovarian hyperstymulation syndrome (OHSS).
Makinoda Satoru
Luteinzed Unruptured Follicle (LUF) can be prevented by Granulocyte Colony-Stimulating Factor (G-CSF)
Inaudi P. 
Hormonal pattern and efficacy of an alternate days rFSH administration for ovarian stimulation in women with polycystic ovaries undergoing IVF/ICSI treatment.
Stefanidis K. 
Bidirectional communication between neural and cardiac cells in human amniotic fluid.
Wardoyo H. 
The influence of based follicle stimulating hormone (FSH) level on successful ovarium stimulation
Hakimi M. 
Early cleavage as a predictor of success rate of in vitro fertilization (IVF) and intra cyto plasmic sperm injection (ICSI)
Albu D. 
Macroprolactinemia, source of misdiagnostic in patients with hiperprolactinemia and infertility
Ruscitto F. 
Factors influencing pregnancy rate in a homologous Intrauterine insemination program
Billebeaud S. 
Transition and Adult follow up in Turner Syndrome
Streda R. 
Risk for OHSS and estradiol level during ovarian stimulation- comparison of long GnRH agonist vs. GnRH antagonist protocol in randomized trial
 
Verde
08.30 - 10.30
PCOS II
Georgopoulos N. 
Insulin Resistance (IR) and Basal Metabolic Rate (BMR) in women with polycystic ovary syndrome (PCOS).
Romualdi D. 
Metmorfin treatment does not affect total leptin levels and free leptin index in obese patients with Polycystic Ovary Syndrome
Matteo M. 
Impaired process of decidualization in women with PCOS is associated with abnormal endometrial lymphocytes fluctuation during the menstrual cycle
Pignatelli D. 
What did the Rotterdam criteria improve in the PCOS diagnosis?
11.00 - 13.30
NEW CONCEPTS IN GYNECOLOGICAL ENDOCRINOLOGY
Mozzanega B. 
Misoprostol in medical illegal abortion
Wilhelm F. 
Phosphorylation of estradiol receptor alpha in human postmenopausal endometrium
Wiksten-Almströmer M. 
Prospective follow-up of menstrual disorders in adolescence and prognostic factors
Maia H. 
Combined treatment of menorrhagia resulting from uterine fibroids by endometrial resection associated with oral gestodene 75 mcg /ethinylestradiol 30 mcg.
Tomic V. 
Non-contraceptive benefits of oral contraception
Lazzeri L. 
Serum inhibin A and inhibin B levels decreases after vaginal estro-progestinic administered
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali

Tuttocongressi ©1995 - 2018 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481